The national essential medicines list of India: Time to revise and purge the mistakes
2010

Revising India's Essential Medicines List

Editorial

Author Information

Author(s): Gitanjali B

Primary Institution: JIPMER, Pondicherry, India

Hypothesis

Why has India not revised its national essential medicines list for seven years despite its importance?

Conclusion

The lack of revision of the national essential medicines list in India could lead to significant negative consequences for patients and healthcare systems.

Supporting Evidence

  • The essential medicines list has been shown to improve access to medicines in many countries.
  • The mistakes in the national essential medicines list can lead to negative implications for procurement and patient care.
  • The lack of revision reflects a broader apathy towards improving healthcare standards.

Takeaway

The list of important medicines in India hasn't been updated in a long time, which can cause problems for patients who need those medicines.

Potential Biases

There is a risk of bias due to the reliance on a small group of individuals for creating guidelines and lists.

Limitations

The commentary reflects a lack of action and engagement from pharmacologists regarding the essential medicines list.

Digital Object Identifier (DOI)

10.4103/0976-500X.72346

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication